Found 63 matching trials
Extended Release Naltrexone for Opioid-Dependent Youth PHASE4 The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Show More Location
Friends Research Institute
Learn More & Join Trial
Buprenorphine Naltrexone-P1 A-Cocaine PHASE1 The purpose of this study is to determine if the opioid agonist effects of ...
Show More Location
Drug Dependence Research Center
Learn More & Join Trial
Comparison of Three Opioid Detoxification Treatment Regimens PHASE3 Despite an increased focus on treating opioid use disorder there are relati...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101) PHASE1 PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Show More Location
PRA Health Sciences - Early Development Services
Learn More & Join Trial
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain PHASE3 The primary objective of the study is to determine the analgesic efficacy a...
Show More Location
Coastal Clinical Research, Inc.
Learn More & Join Trial
Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults PHASE4 This study seeks to compare the effectiveness of two medications used to tr...
Show More Location
Yale University School of Medicine
Learn More & Join Trial
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America PHASE4 The purpose of this post approval pragmatic clinical study is to see how we...
Show More Location
Nutrition Research Centre
Learn More & Join Trial
Medication Maintenance Therapy in Community Pharmacy Settings EARLY_PHASE1 The goal of this study is to examine how the pharmacy can better optimize t...
Show More Location
Rhode Island Hospital
Learn More & Join Trial
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions PHASE1 To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder PHASE3 This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Show More Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Learn More & Join Trial